Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1245.50

-24.30 (-1.91%)

< Home < Back

USFDA completes audit at Dr. Reddy’s Laboratories’ Hyderabad plant

Date: 12-07-2019

US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy’s Laboratories’ API Manufacturing Plant 2 at Bollaram, Hyderabad. The audit was completed on July 12, 2019. The company has been issued a Form 483 with 5 observations.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.